Evidence that somatostatin sst2 receptors mediate striatal dopamine release

British Journal of Pharmacology

Volumn 128, Issue 6, 1999, Pages 1346-1352

  Hathway, G J ^a,b   Humphrey, P P A ^a   Kendrick, K M ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Dopamine; GABA; Glutamate; Microdialysis; Rat; Somatostatin; Striatum

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR ANTAGONIST; BIM 23027; DOPAMINE; HORMONE RECEPTOR BLOCKING AGENT; KAINIC ACID RECEPTOR ANTAGONIST; NEUROTRANSMITTER; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; 1 [3 [N (5 BROMO 2 PYRIDYL) N (3,4 DICHLOROBENZYL)AMINO]PROPYL] 3 [3 (4 IMIDAZOLYL)PROPYL]THIOUREA; 2 AMINO 5 PHOSPHONOVALERIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; AMINO ACID RECEPTOR BLOCKING AGENT; AMINOPYRIDINE DERIVATIVE; CYCLOPEPTIDE; CYN 154806; DEXTRO PHENYLALANYLPHENYLALANYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLPHENYLALANYL DEXTRO [3 (2 NAPHTHYL)ALANINAMIDE]; DRUG DERIVATIVE; L 362855; OLIGOPEPTIDE; QUINOXALINE DERIVATIVE; THIOUREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; ELECTROCHEMISTRY; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CORPUS STRIATUM; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; PHYSIOLOGY; SECRETION; WISTAR RAT;

2-AMINO-5-PHOSPHONOVALERATE; AMINOPYRIDINES; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; MALE; NEUROTRANSMITTER AGENTS; OLIGOPEPTIDES; PEPTIDES, CYCLIC; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; THIOUREA;

EID: 0032586079     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702934     Document Type: Article

References (29)

1. ANKERSEN, M., CRIDER, M., LIU, S.Q., ANDERSEN, H.S. & STIDSEN, C. (1998). Discovery of a novel non-peptide somatostatin agonist with SST 4 selectivity. J. Am. Chem. Soc., 120, 1368-1373.
2. BASS, R.T., BUCKWALTER, B.L., PATEL, B.P., PAUSCH, M.H., PRICE, L.A., STRNAD, J. & HADCOCK, J.R. (1996). Identification and characterization of novel somatostatin antagonists. Mol. Pharmacol., 50, 709-715.
3. BELL, G.I. & REISINE, T. (1993). Molecular biology of somatostatin receptors. TiNS, 16, 34-38.
4. BRAZEAU, P., VALE, W., BURGUS, R., LING, N., BUTCHER, M., RIVIER, G. & GUILLEMIN, R. (1973). Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science, 179, 77-99.
5. CASTRO, S.W., BUELL, G., FENIUK, W. & HUMPHREY, P.P.A. (1996). Differences in the operational characteristics of the human recombinant somatostatin receptor types, sst(1) and sst(2) in mouse fibroblast (Ltk(-)) cells. Br. J. Pharmacol., 117, 639-646.
6. CHESSELL, I.P., BLACK, M.D., FENIUK, W. & HUMPHREY, P.P.A. (1996). Operational characteristics of somatostatin receptors mediating inhibitory actions on rat locus coeruleus neurones. Br. J. Pharmacol., 117, 1673-1678.
7. DOURNAUD, P., BOUDIN, H., SCHONBRUNN, A., TANNENBAUM, G.S. & BEAUDET, A. (1998). Interrelationships between somatostatin sst2A receptors and somatostatin-containing axons in rat brain: Evidence for regulation of cell surface receptors by endogenous somatostatin. J. Neurosci., 18, 1056-1071.
8. EPELBAUM, J., BRAZEAU, P., TSANG, D., BRAWER, J. & MARTIN, J.B. (1977). Subcellular distribution of radio-immunoassayable somatostatin in the rat brain. Brain Res., 126, 377-383.
9. 2 (Cyanamid 154806). Br. J. Pharmacol., 123, 111P.
10. HATHWAY, G.J., EMSON, P.C., HUMPHREY, P.P.A. & KENDRICK, K.M. (1998). Somatostatin potently stimulates in vivo striatal dopamine and γ-aminobutyric acid release by a glutamate-dependent action. J. Neurochem., 70, 1740-1749.
11. HICKS, G.A., FENIUK, W. & HUMPHREY, P.P.A. (1998). Outward current produced by somatostatin (SRIF) in anterior cingulate pyramidal cells in vitro. Br. J. Pharmacol., 124, 252-258.
12. IVERSEN, L.L., IVERSEN, S.D., BLOOM, F., DOUGLAS, C., BROWN, M. & VAL, W.W. (1978). Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro. Nature, 273, 61-163.
13. KAWAGUCHI, Y., WILSON, C.J., AUGOOD, S.J. & EMSON, P.C. (1995). Striatal interneurones: chemical, physiological and morphological characterization. TiNS, 18, 527-535.
14. KENDRICK, K.M., GUEVARA-GUZMAN, R., DE LA RIVA, C., CHRISTENSEN, J., ØSTERGAARD, K. & EMSON, P.C. (1996). NMDA and kainate-evoked release of nitric oxide and transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role. Eur. J. Neurosci., 8, 2619-2634.
15. PELLEGRINO J.J. & PELLEGRINO A.S. (1979). A Stereotaxic Atlas of the Rat Brain. Plenum, New York.
16. SCHINDLER, M., HUMPHREY, P.P.A. & EMSON, P.C. (1996). Somatostatin receptors in the central nervous system. Prog. Neurobiol., 50, 17-20.
17. SCHINDLER, M., HUMPHREY, P.P.A., LOHRKE, S. & FRIAUF, E. (1999). Immunohistochemical localization of the somatostain sst(2(b)) receptor splice variant in the rat central nervous system. Neuroscience., 90, 859-874.
18. SCHINDLER, M., SELLERS, L.A., HUMPHREY, P.P.A. & EMSON, P.C. (1997). Immunohistochemical localization of the somatostatin SST2 (A) receptor in the rat brain and spinal cord. Neuroscience, 76, 225-240.
19. SELLERS, L.A., FENIUK, W., HUMPHREY, P.P.A. & LAUDER, H. (1999). Activated G protein coupled receptor induces tyrosine phosphorylation of STAT3 and agonist-selective serine phosphorylation via sustained stimulation of mitogen-activated protein kinase. Resultant effects on cell proliferation. J. Biol. Chem., 274, 16423-16430.
20. SENARIS, R.M., HUMPHREY, P.P.A. & EMSON, P.C. (1994). Distribution of somatostatin receptors 1, 2 and 3 mRNA in rat brain and pituitary. Eur. J. Neurosci., 6, 1883-1896.
21. SMALLEY, G.W., COATS, D.W. & ADAM, E.J. (1998). Differential agonist activity of somatostatin and L-362855 at human recombinant sst4 receptors. Br. J. Pharmacol., 125, 833-841.
22. 2+ current in the pituitary cell line AtT-20. Neuroscience, 71, 1073-1081.
23. VANETTI, J., KERKIRION, L., KACHIDIAN, P., BOSTER, O. & HÖLLT, V. (1992). Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett., 331, 290-294.
24. VINCENT, S.R. & JOHANSSON, O. (1983). Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: a light and electron microscopic study. J. Comp. Neurol., 217, 264-270.
25. VUILLET, J., KERKERION, L., KACHIDIAN, P., BOSTER, O. & NIEOULLON, A. (1989). Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibres and neuropeptide-Y-containing neurons in the rat striatum. Neurosci. Lett., 100, 99-104.
26. 5 receptors mediating activation of phosphoinositide metabolism. Br. J. Pharmacol., 121, 91-96.
27. 5 receptor. Br. J. Pharmacol., 118, 445-447.
28. 35S]guanosine-5′-O-(3-thio-triphosphate binding: agonist potencies and the influence of sodium chloride on intrinsic activity. Mol. Pharmacol., 51, 1060-1069.
29. 2 receptor-mediated inhibition of parietal cell function in rat isolated gastric mucosa. Br. J. Pharmacol., 119, 1673-1678.